Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


18.04.2017

7 AIDS
8 AIDS Res Hum Retroviruses
1 Am J Epidemiol
1 Antimicrob Agents Chemother
1 Antivir Ther
1 Blood
1 BMC Pediatr
1 Immunology
23 J Acquir Immune Defic Syndr
3 J Infect Dis
2 J Med Virol
1 J Virol
5 Lancet Gastroenterol Hepatol
2 Lancet Glob Health
1 N Engl J Med
5 Pediatr Infect Dis J
2 PLoS Med
12 PLoS One
2 Proc Natl Acad Sci U S A
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. PUTCHAROEN O, Wattanachanya L, Sophonphan J, Siwamogsatham S, et al
    New-onset diabetes in hiv treated adults from thailand: predictors, long-term renal and cardiovascular outcomes.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001496.
    PubMed     Text format     Abstract available

  2. UBAIDA-MOHIEN C, Lamberty B, Dickens AM, Mielke MM, et al
    Informatic interrogation of CSF proteomic profiles from HIV-infected subjects implicates acute phase and complement systems in shifting cognitive status.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001503.
    PubMed     Text format     Abstract available

  3. SWEENEY P, Gray SC, Purcell DW, Sewell J, et al
    Association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001501.
    PubMed     Text format     Abstract available

  4. FORHAN SE, Modi S, Houston JC, Broyles LN, et al
    Moving towards test and start: learning from the experience of universal ART programs for HIV-infected pregnant/breastfeeding women.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001498.
    PubMed     Text format     Abstract available

  5. INZAULE SC, Hamers RL, Mukui I, Were K, et al
    Emergence of untreatable, multidrug-resistant HIV-1 in patients failing second-line therapy in Kenya.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001500.
    PubMed     Text format     Abstract available

  6. MAURICE JB, Patel A, Scott AJ, Patel K, et al
    Prevalence and risk factors of non-alcoholic fatty liver disease in HIV-monoinfection: a systematic review and meta-analysis.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001504.
    PubMed     Text format     Abstract available

  7. MCGRATH N, Grapsa E
    Does ART change partnership dynamics and HIV risk behaviours among PLWH? A cohort study in KwaZulu-Natal, South Africa.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001502.
    PubMed     Text format     Abstract available


    AIDS Res Hum Retroviruses

  8. ERLANDSON KM, Fiorillo SP, Cardoso SW, Rivere C, et al
    Insulin-like Growth Factor is Associated with Changes in Body Composition with ART Initiation.
    AIDS Res Hum Retroviruses. 2017 Apr 12. doi: 10.1089/AID.2016.0327.
    PubMed     Text format     Abstract available

  9. ASHOKKUMAR M, Nesakumar M, Narayanaiah C, Kk VV, et al
    Molecular characteristics of the envelope of vertically transmitted HIV-1 strains from infants with HIV infection.
    AIDS Res Hum Retroviruses. 2017 Apr 12. doi: 10.1089/AID.2016.0260.
    PubMed     Text format     Abstract available

  10. FUJIMOTO K, Coghill LM, Weier CA, Hwang LY, et al
    Lack of Support for Socially Connected HIV-1 Transmission among Young Adult Black MSM.
    AIDS Res Hum Retroviruses. 2017 Feb 24. doi: 10.1089/AID.2016.0228.
    PubMed     Text format     Abstract available

  11. THOMPSON C, Gay CL, Kashuba A
    HIV Persistence in GALT: Pharmacological Challenges and Opportunities.
    AIDS Res Hum Retroviruses. 2017 Feb 28. doi: 10.1089/AID.2016.0253.
    PubMed     Text format     Abstract available

  12. THURMAN AR, Yousefieh N, Chandra N, Kimble TD, et al
    Comparison of Mucosal Markers of HIV Susceptibility in Healthy Premenopausal versus Postmenopausal Women.
    AIDS Res Hum Retroviruses. 2017 Apr 11. doi: 10.1089/AID.2016.0320.
    PubMed     Text format     Abstract available

  13. VALDIVIA A, Ly J, Gonzalez L, Hussain P, et al
    Restoring cytokine balance in HIV Positive Individuals with Low CD4 T Cell Counts.
    AIDS Res Hum Retroviruses. 2017 Apr 11. doi: 10.1089/AID.2016.0303.
    PubMed     Text format     Abstract available

  14. KARRIS M
    Resolution of Tenofovir Disoproxil Fumarate Induced Fanconi Syndrome with Switch to Tenofovir Alafenamide Fumarate in a HIV-1 and Hepatitis B co-infected Patient.
    AIDS Res Hum Retroviruses. 2017 Apr 13. doi: 10.1089/AID.2016.0180.
    PubMed     Text format     Abstract available

  15. WANG X, Zhang M, Li J, Li T, et al
    Genetic Characterization of a Unique Recombinant strain identified in Yunnan with genome comprised of B and C.
    AIDS Res Hum Retroviruses. 2017 Feb 10. doi: 10.1089/AID.2017.0013.
    PubMed     Text format     Abstract available


    Am J Epidemiol

  16. HICKSON DA, Mena LA, Wilton L, Tieu HV, et al
    Sexual Networks, Dyadic Characteristics, and HIV Acquisition and Transmission Behaviors Among Black Men Who Have Sex With Men in 6 US Cities.
    Am J Epidemiol. 2017 Apr 10:1-15. doi: 10.1093.
    PubMed     Text format     Abstract available


    Antimicrob Agents Chemother

  17. DAS K, Martinez SE, Arnold E
    Structural Insights into HIV Reverse Transcriptase Mutations Q151M and Q151M Complex that Confer Multi-Nucleoside Drug Resistance.
    Antimicrob Agents Chemother. 2017 Apr 10. pii: AAC.00224.
    PubMed     Text format     Abstract available


    Antivir Ther

  18. TROTTIER B, Lake JE, Logue K, Brinson C, et al
    Dolutegravir/abacavir/lamivudine versus current ART in virally suppressed patients (STRIIVING): a 48-week, randomized, non-inferiority, open-label, Phase IIIb study.
    Antivir Ther. 2017 Apr 12. doi: 10.3851/IMP3166.
    PubMed     Text format     Abstract available


    Blood

  19. NOY A
    HIV multicentric Castleman: rituximab sans maintenance.
    Blood. 2017;129:2045-2046.
    PubMed     Text format    


    BMC Pediatr

  20. DHITAL S, Sherchand JB, Pokhrel BM, Parajuli K, et al
    Molecular epidemiology of Rotavirus causing diarrhea among children less than five years of age visiting national level children hospitals, Nepal.
    BMC Pediatr. 2017;17:101.
    PubMed     Text format     Abstract available


    Immunology

  21. JAUMDALLY SZ, Picton A, Tiemessen CT, Paximadis M, et al
    CCR5 expression, haplotype and immune activation in protection from infection in HIV-exposed uninfected individuals in HIV serodiscordant relationships.
    Immunology. 2017 Apr 11. doi: 10.1111/imm.12743.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  22. KIRAGU K, Collins L, Von Zinkernagel D, Mushavi A, et al
    Integrating PMTCT Into Maternal, Newborn, and Child Health and Related Services: Experiences From the Global Plan Priority Countries.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S36-S42.
    PubMed     Text format     Abstract available

  23. KALUA T, Tippett Barr BA, van Oosterhout JJ, Mbori-Ngacha D, et al
    Lessons Learned From Option B+ in the Evolution Toward "Test and Start" From Malawi, Cameroon, and the United Republic of Tanzania.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S43-S50.
    PubMed     Text format     Abstract available

  24. HAMILTON E, Bossiky B, Ditekemena J, Esiru G, et al
    Using the PMTCT Cascade to Accelerate Achievement of the Global Plan Goals.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S27-S35.
    PubMed     Text format     Abstract available

  25. ESSAJEE S, Bhairavabhotla R, Penazzato M, Kiragu K, et al
    Scale-up of Early Infant HIV Diagnosis and Improving Access to Pediatric HIV Care in Global Plan Countries: Past and Future Perspectives.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S51-S58.
    PubMed     Text format     Abstract available

  26. PENAZZATO M, Amzel A, Abrams EJ, Kiragu K, et al
    Pediatric Treatment Scale-Up: The Unfinished Agenda of the Global Plan.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S59-S65.
    PubMed     Text format     Abstract available

  27. ABDOOL KARIM Q, Baxter C, Birx D
    Prevention of HIV in Adolescent Girls and Young Women: Key to an AIDS-Free Generation.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S17-S26.
    PubMed     Text format     Abstract available

  28. LUO C, Hirnschall G, Rodrigues J, Romano S, et al
    Translating Technical Support Into Country Action: The Role of the Interagency Task Team on the Prevention and Treatment of HIV Infection in Pregnant Women, Mothers, and Children in the Global Plan Era.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S7-S16.
    PubMed     Text format     Abstract available

  29. PERKINS M, Bradley W, Lalani T, Agan B, et al
    Prevalence of Post-Treatment Controller Phenotype is Rare in HIV-infected Persons after Stopping Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001393.
    PubMed     Text format     Abstract available

  30. XIA Q, Zhong Y, Wiewel EW, Braunstein SL, et al
    Linkage to Care after HIV Diagnosis in New York City: Better Than We Thought.
    J Acquir Immune Defic Syndr. 2017 Apr 10. doi: 10.1097/QAI.0000000000001419.
    PubMed     Text format    

  31. SENA AC, Donovan J, Swygard H, Clymore J, et al
    The North Carolina HIV Bridge Counselor Program: outcomes from a statewide level intervention to link and re-engage HIV-infected persons in care in the South.
    J Acquir Immune Defic Syndr. 2017 Apr 6. doi: 10.1097/QAI.0000000000001389.
    PubMed     Text format     Abstract available

  32. HAROZ D, von Zinkernagel D, Kiragu K
    Development and Impact of the Global Plan.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S2-S6.
    PubMed     Text format     Abstract available

  33. BROWN LB, Ayieko J, Mwangwa F, Owaraganise A, et al
    Predictors of retention in HIV care among youth (15-24) in a universal test-and-treat setting in rural Kenya.
    J Acquir Immune Defic Syndr. 2017 Apr 6. doi: 10.1097/QAI.0000000000001390.
    PubMed     Text format    

  34. DUBROW R, Qin L, Lin H, Hernandez-Ramirez RU, et al
    Associations of CD4+ T-cell count, HIV-1 RNA viral load, and antiretroviral therapy with Kaposi sarcoma risk among HIV-infected persons in the United States and Canada.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001394.
    PubMed     Text format     Abstract available

  35. RADIN AK, Abutu AA, Okwero MA, Adler MR, et al
    Confronting Challenges in Monitoring and Evaluation: Innovation in the Context of the Global Plan Towards the Elimination of New HIV Infections Among Children by 2015 and Keeping Their Mothers Alive.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S66-S75.
    PubMed     Text format     Abstract available

  36. MODI S, Callahan T, Rodrigues J, Kajoka MD, et al
    Overcoming Health System Challenges for Women and Children Living With HIV Through the Global Plan.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S76-S85.
    PubMed     Text format     Abstract available

  37. MATHESON R, Brion S, Sharma A, Dilmitis S, et al
    Realizing the Promise of the Global Plan: Engaging Communities and Promoting the Health and Human Rights of Women Living With HIV.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S86-S93.
    PubMed     Text format     Abstract available

  38. KELLY JD, Reid MJ, Lahiff M, Tsai AC, et al
    Community-level HIV stigma as a driver for HIV transmission risk behaviors and sexually transmitted diseases in Sierra Leone: a population-based study.
    J Acquir Immune Defic Syndr. 2017 Apr 12. doi: 10.1097/QAI.0000000000001418.
    PubMed     Text format     Abstract available

  39. NAIKOBA S, Senjovu KD, Mugabe P, McCarthy C, et al
    Improved HIV and TB knowledge and competence among mid-level providers in a cluster-randomized trial of one-on-one mentorship for task-shifting.
    J Acquir Immune Defic Syndr. 2017 Apr 12. doi: 10.1097/QAI.0000000000001378.
    PubMed     Text format     Abstract available

  40. IZZO I, Quiros-Roldan E, Casari S, Gargiulo F, et al
    Characteristics and Outcome of a Cohort of HIV-1 Non-B Subtype-Infected Patients After a 10-Year Follow-up Period: A Single Centre Experience.
    J Acquir Immune Defic Syndr. 2017;75:e23-e24.
    PubMed     Text format    

  41. PATEL RC, Baeten JM, Heffron R, Hong T, et al
    Brief Report: Hormonal Contraception Is Not Associated With Reduced ART Effectiveness Among Women Initiating ART: Evidence From Longitudinal Data.
    J Acquir Immune Defic Syndr. 2017;75:91-96.
    PubMed     Text format     Abstract available

  42. GOOSBY E, Abrams E, Bekker LG, Mushavi A, et al
    Crossing the Finish Line.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S106-S107.
    PubMed     Text format    

  43. VITILLO RJ, Merico F, Levine AS, Buonocore T, et al
    A Comprehensive Response: The Role of Nonstate Actors in the Global Plan.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S99-S105.
    PubMed     Text format     Abstract available

  44. LYONS C, Pillay Y
    Understanding the Role and Impact of Effective Country and Community Leadership in Progress Toward the Global Plan.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S94-S98.
    PubMed     Text format     Abstract available


    J Infect Dis

  45. CHAN PA, Flanigan TP
    Effective HIV Prevention Interventions and the Need for Rapid Mobilization to Address HIV Outbreaks Among At-Risk Populations.
    J Infect Dis. 2017 Apr 12. doi: 10.1093.
    PubMed     Text format    

  46. HERRERA BB, Chang CA, Hamel DJ, Mboup S, et al
    Continued transmission of Zika virus in humans in West Africa, 1992-2016.
    J Infect Dis. 2017 Apr 8. doi: 10.1093.
    PubMed     Text format     Abstract available

  47. SYPSA V, Psichogiou M, Paraskevis D, Nikolopoulos G, et al
    Rapid Decline in HIV Incidence Among Persons Who Inject Drugs During a Fast-Track Combination Prevention Program After an HIV Outbreak in Athens.
    J Infect Dis. 2017 Apr 12. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Virol

  48. JABLONOWSKA E, Pulik P, Kalinowska A, Gasiorowski J, et al
    "Efficacy and safety of nucleoside-sparing regimen based on raltegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients".
    J Med Virol. 2017 Apr 8. doi: 10.1002/jmv.24826.
    PubMed     Text format     Abstract available

  49. DUBE MANDISHORA RS, Christiansen IK, Chin'ombe N, Duri K, et al
    Genotypic diversity of anogenital human papillomavirus in women attending cervical cancer screening in Harare, Zimbabwe.
    J Med Virol. 2017 Apr 8. doi: 10.1002/jmv.24825.
    PubMed     Text format     Abstract available


    J Virol

  50. REEVES DB, Peterson CW, Kiem HP, Schiffer JT, et al
    Autologous stem-cell transplantation disrupts adaptive immune responses during rebound SHIV viremia.
    J Virol. 2017 Apr 12. pii: JVI.00095-17. doi: 10.1128/JVI.00095.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  51. VERNA EC
    Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV.
    Lancet Gastroenterol Hepatol. 2017;2:211-223.
    PubMed     Text format     Abstract available

  52. ISLAM N, Krajden M, Shoveller J, Gustafson P, et al
    Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.
    Lancet Gastroenterol Hepatol. 2017;2:200-210.
    PubMed     Text format     Abstract available

  53. CHAN HL, Fung S, Seto WK, Chuang WL, et al
    Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.
    Lancet Gastroenterol Hepatol. 2016;1:185-195.
    PubMed     Text format     Abstract available

  54. ROCKSTROH JK, Bhagani S, Hyland RH, Yun C, et al
    Ledipasvir-sofosbuvir for 6 weeks to treat acute hepatitis C virus genotype 1 or 4 infection in patients with HIV coinfection: an open-label, single-arm trial.
    Lancet Gastroenterol Hepatol. 2017;2:347-353.
    PubMed     Text format     Abstract available

  55. HAJARIZADEH B, Grebely J, Martinello M, Matthews GV, et al
    Hepatitis C treatment as prevention: evidence, feasibility, and challenges.
    Lancet Gastroenterol Hepatol. 2016;1:317-327.
    PubMed     Text format     Abstract available


    Lancet Glob Health

  56. LOCKMAN S, Hughes M, Powis K, Ajibola G, et al
    Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial.
    Lancet Glob Health. 2017;5:e491-e500.
    PubMed     Text format     Abstract available

  57. EVANS C, Prendergast AJ
    Co-trimoxazole for HIV-exposed uninfected infants.
    Lancet Glob Health. 2017;5:e468-e469.
    PubMed     Text format    


    N Engl J Med

  58. MARKS PW
    The Blood Supply and Men Who Have Sex with Men.
    N Engl J Med. 2017;376:1486.
    PubMed     Text format    


    Pediatr Infect Dis J

  59. KELLY MS, Surette MG, Smieja M, Pernica JM, et al
    The Nasopharyngeal Microbiota of Children with Respiratory Infections in Botswana.
    Pediatr Infect Dis J. 2017 Apr 10. doi: 10.1097/INF.0000000000001607.
    PubMed     Text format     Abstract available

  60. MAJEKODUNMI AO, Thorne C, Malyuta R, Volokha A, et al
    Modelling CD4 T Cell Recovery in Hepatitis C and HIV Co-infected Children Receiving Antiretroviral Therapy.
    Pediatr Infect Dis J. 2017;36:e123-e129.
    PubMed     Text format     Abstract available

  61. LAZARUS E, Nicol S, Frigati L, Penazzato M, et al
    Second- and Third-line Antiretroviral Therapy for Children and Adolescents: A Scoping Review.
    Pediatr Infect Dis J. 2017;36:492-499.
    PubMed     Text format     Abstract available

  62. JOAO EC, Gouvea MI, Teixeira ML, Mendes-Silva W, et al
    Zika Virus Infection Associated With Congenital Birth Defects in a HIV-infected Pregnant Woman.
    Pediatr Infect Dis J. 2017;36:500-501.
    PubMed     Text format     Abstract available

  63. LEVIN C, Le Roux D, Harrison M, Tooke L, et al
    HIV Transmission to Premature Very Low Birth Weight Infants.
    Pediatr Infect Dis J. 2017 Apr 13. doi: 10.1097/INF.0000000000001611.
    PubMed     Text format     Abstract available


    PLoS Med

  64. SHARMA M, Barnabas RV, Celum C
    Community-based strategies to strengthen men's engagement in the HIV care cascade in sub-Saharan Africa.
    PLoS Med. 2017;14:e1002262.
    PubMed     Text format     Abstract available

  65. FOX MP, Rosen S
    A new cascade of HIV care for the era of "treat all".
    PLoS Med. 2017;14:e1002268.
    PubMed     Text format     Abstract available


    PLoS One

  66. DE BOER R, Musgrave J, Andersson N, Lutscher F, et al
    The importance of choice disability and structural intervention in the HIV epidemic in Sub-Saharan Africa.
    PLoS One. 2017;12:e0175297.
    PubMed     Text format     Abstract available

  67. ODHIAMBO C, Omolo P, Oyaro B, Williamson J, et al
    Establishment of reference intervals during normal pregnancy through six months postpartum in western Kenya.
    PLoS One. 2017;12:e0175546.
    PubMed     Text format     Abstract available

  68. PIRONTI A, Pfeifer N, Walter H, Jensen BO, et al
    Using drug exposure for predicting drug resistance - A data-driven genotypic interpretation tool.
    PLoS One. 2017;12:e0174992.
    PubMed     Text format     Abstract available

  69. ALSALLAQ RA, Buttolph J, Cleland CM, Hallett T, et al
    The potential impact and cost of focusing HIV prevention on young women and men: A modeling analysis in western Kenya.
    PLoS One. 2017;12:e0175447.
    PubMed     Text format     Abstract available

  70. WU Y, Ren X, Yin D, Wang H, et al
    Characterization of a novel HIV-1 unique recombinant form between CRF07_BC and CRF55_01B in men who have sex with men in Guangzhou, China.
    PLoS One. 2017;12:e0175770.
    PubMed     Text format     Abstract available

  71. ABIMANYI-OCHOM J, Mannan H, Groce NE, McVeigh J, et al
    HIV/AIDS knowledge, attitudes and behaviour of persons with and without disabilities from the Uganda Demographic and Health Survey 2011: Differential access to HIV/AIDS information and services.
    PLoS One. 2017;12:e0174877.
    PubMed     Text format     Abstract available

  72. BEBELL LM, Ngonzi J, Bazira J, Fajardo Y, et al
    Antimicrobial-resistant infections among postpartum women at a Ugandan referral hospital.
    PLoS One. 2017;12:e0175456.
    PubMed     Text format     Abstract available

  73. ADINAN J, Damian DJ, Mosha NR, Mboya IB, et al
    Individual and contextual factors associated with appropriate healthcare seeking behavior among febrile children in Tanzania.
    PLoS One. 2017;12:e0175446.
    PubMed     Text format     Abstract available

  74. LOU J, Hu P, Qian HZ, Ruan Y, et al
    Expanded antiretroviral treatment, sexual networks, and condom use: Treatment as prevention unlikely to succeed without partner reduction among men who have sex with men in China.
    PLoS One. 2017;12:e0171295.
    PubMed     Text format     Abstract available

  75. FLAX VL, Hamela G, Mofolo I, Hosseinipour MC, et al
    Factors influencing postnatal Option B+ participation and breastfeeding duration among HIV-positive women in Lilongwe District, Malawi: A qualitative study.
    PLoS One. 2017;12:e0175590.
    PubMed     Text format     Abstract available

  76. VAN HOUT A, D'huys T, Oeyen M, Schols D, et al
    Comparison of cell-based assays for the identification and evaluation of competitive CXCR4 inhibitors.
    PLoS One. 2017;12:e0176057.
    PubMed     Text format     Abstract available

  77. XU W, Zheng L, Zheng Y
    Prevalence of non-contact and contact childhood sexual abuse: An Internet-based sample of men who have sex with men in China.
    PLoS One. 2017;12:e0175444.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  78. CAI Y, Karaca-Griffin S, Chen J, Tian S, et al
    Antigenicity-defined conformations of an extremely neutralization-resistant HIV-1 envelope spike.
    Proc Natl Acad Sci U S A. 2017 Apr 10. pii: 201700634.
    PubMed     Text format     Abstract available

  79. XIE J, Sok D, Wu NC, Zheng T, et al
    Immunochemical engineering of cell surfaces to generate virus resistance.
    Proc Natl Acad Sci U S A. 2017 Apr 10. pii: 201702764.
    PubMed     Text format     Abstract available


    Vaccine

  80. MELNYCHUK L, Ajamian L, Jean-Pierre P, Liang J, et al
    Development of a DNA vaccine expressing a secreted HIV-1 gp41 ectodomain that includes the membrane-proximal external region.
    Vaccine. 2017 Apr 6. pii: S0264-410X(17)30355.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: